Formulation and antitumorigenic activities of nanoencapsulated nifetepimine: A promising approach in treating triple negative breast carcinoma
- 1 October 2016
- journal article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 12 (7) , 1973-1985
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Neuroprotective Role of Nanoencapsulated Quercetin in Combating Ischemia-Reperfusion Induced Neuronal Damage in Young and Aged RatsPLOS ONE, 2013
- Mitochondrial Ca2+ and apoptosisCell Calcium, 2012
- Triple-negative breast cancer: are we making headway at least?Therapeutic Advances in Medical Oncology, 2012
- Toxicological considerations when creating nanoparticle-based drugs and drug delivery systemsExpert Opinion on Drug Metabolism & Toxicology, 2011
- Polymeric Nanoparticles for Increased Oral Bioavailability and Rapid Absorption Using Celecoxib as a Model of a Low-Solubility, High-Permeability DrugPharmaceutical Research, 2011
- Enhanced Anticancer Effect of the Combination of Cisplatin and TRAIL in Triple-Negative Breast Tumor CellsMolecular Cancer Therapeutics, 2011
- Nanomedicinal Strategies to Treat Multidrug-Resistant Tumors: Current ProgressNanomedicine, 2010
- Triple-Negative Breast CancerThe Cancer Journal, 2010
- Circumventing Tumor Resistance to Chemotherapy by Nanotechnology2009
- Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosisOncogene, 2008